1. Oridonin inhibits oral cancer growth and PI3K/Akt signaling pathway
   Jing Yang et al, 2018, Biomedicine & Pharmacotherapy CrossRef
2. Phytochemicals and mitochondria: Therapeutic allies against gastric cancer
   Maoyuan Zhao et al, 2023, Phytomedicine CrossRef
3. Research Progress and Future Development Potential of Oridonin in Pharmacological Activities
   Jinhuan Jiang et al, 2023, Current Molecular Pharmacology CrossRef
4. Key Targets and Molecular Mechanisms of Active Volatile Components of Rabdosia rubescens in Gastric Cancer Cells
   Yanhui Hu et al, 2022, Current Computer-Aided Drug Design CrossRef
5. Oridonin induces apoptosis in HGC‑27 cells by activating the JNK signaling pathway
   Dong‑Lin Ren et al, 2019, Oncology Letters CrossRef
6. The Natural Product Oridonin as an Anticancer Agent: Current Achievements and Problems
   Xiangyan Hu et al, 2024, Current Pharmaceutical Biotechnology CrossRef
7. R-Phycoerythrin Induces SGC-7901 Apoptosis by Arresting Cell Cycle at S Phase
   Huixin Tan et al, 2016, Marine Drugs CrossRef
8. Structural modification of oridonin via DAST induced rearrangement
   Dong-Dong Luo et al, 2018, RSC Advances CrossRef
9. Oridonin interrupts cellular bioenergetics to suppress glioma cell growth by down‐regulating PCK2
   Jianhu Lin et al, 2021, Phytotherapy Research CrossRef
10. Cetuximab enhances oridonin-induced apoptosis through mitochondrial pathway and endoplasmic reticulum stress in laryngeal squamous cell carcinoma cells
    Ning Kang et al, 2020, Toxicology in Vitro CrossRef
11. Oridonin Suppresses Human Gastric Cancer Growth in Vitro and in Vivo via Inhibition of VEGF, Integrin β3, and PCNA
    Qiong Yang et al, 2020, Biological and Pharmaceutical Bulletin CrossRef
12. Oridonin suppresses gastric cancer SGC‐7901 cell proliferation by targeting the TNF‐alpha/androgen receptor/TGF‐beta signalling pathway axis
    Shiyong Gao et al, 2023, Journal of Cellular and Molecular Medicine CrossRef
13. Oridonin induces growth inhibition and apoptosis in human gastric carcinoma cells by enhancement of p53 expression and function
    Enxu Bi et al, 2018, Brazilian Journal of Medical and Biological Research CrossRef
14. Apoptotic Pathway as the Therapeutic Target for Anticancer Traditional Chinese Medicines
    Weixiao An et al, 2019, Frontiers in Pharmacology CrossRef
15. Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine
    Hua Luo et al, 2019, Chinese Medicine CrossRef
16. Metformin inhibits the proliferation of canine mammary gland tumor cells through the AMPK/AKT/mTOR signaling pathway in vitro
    Yuying Fan et al, 2021, Oncology Letters CrossRef
17. Oridonin promotes endoplasmic reticulum stress via TP53-repressed TCF4 transactivation in colorectal cancer
    Fangyuan Zhou et al, 2023, Journal of Experimental & Clinical Cancer Research CrossRef
18. The Curcumin Analogue, MS13 (1,5-Bis(4-hydroxy-3- methoxyphenyl)-1,4-pentadiene-3-one), Inhibits Cell Proliferation and Induces Apoptosis in Primary and Metastatic Human Colon Cancer Cells
    Nor Isnida Ismail et al, 2020, Molecules CrossRef
19. Oridonin inhibition and miR-200b-3p/ZEB1 axis in human pancreatic cancer
    Zhifang Gui et al, 2017, International Journal of Oncology CrossRef
20. Oridonin: A Review of Its Pharmacology, Pharmacokinetics and Toxicity
    Xiang Li et al, 2021, Frontiers in Pharmacology CrossRef
21. Natural products: A lead for drug discovery and development
    Bhawna Chopra et al, 2021, Phytotherapy Research CrossRef
22. The bioengineered and multifunctional nanoparticles in pancreatic cancer therapy: Bioresponisive nanostructures, phototherapy and targeted drug delivery
    Mohamed J. Saadh et al, 2023, Environmental Research CrossRef
23. Oridonin inhibits hypoxia-induced epithelial–mesenchymal transition and cell migration by the hypoxia-inducible factor-1α/matrix metallopeptidase-9 signal pathway in gallbladder cancer
    Kunlun Chen et al, 2019, Anti-Cancer Drugs CrossRef
24. Mechanistic Pathways and Molecular Targets of Plant-Derived Anticancer ent-Kaurane Diterpenes
    Md. Shahid Sarwar et al, 2020, Biomolecules CrossRef
25. Oridonin inhibits the migration and epithelial‐to‐mesenchymal transition of small cell lung cancer cells by suppressing FAK‐ERK1/2 signalling pathway
    Linhao Xu et al, 2020, Journal of Cellular and Molecular Medicine CrossRef